Tofogliflozin
98%
- Product Code: 102972
CAS:
903565-83-3
| Molecular Weight: | 386.44 g./mol | Molecular Formula: | C₂₂H₂₆O₆ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Tofogliflozin is primarily used in the treatment of type 2 diabetes mellitus. It functions as a sodium-glucose co-transporter 2 (SGLT2) inhibitor, which helps to lower blood glucose levels by preventing the reabsorption of glucose in the kidneys. This leads to increased excretion of glucose through urine, thereby reducing overall blood sugar levels. It is often prescribed when other diabetes medications have not provided adequate control. Additionally, Tofogliflozin has shown potential benefits in reducing cardiovascular risks, which is particularly important for diabetic patients who are at higher risk for heart-related complications. It is typically administered orally and is part of a comprehensive diabetes management plan that includes diet, exercise, and regular monitoring of blood glucose levels.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.002 | 10-20 days | $1,077.41 |
+
-
|
| 0.005 | 10-20 days | $1,846.98 |
+
-
|
Tofogliflozin
Tofogliflozin is primarily used in the treatment of type 2 diabetes mellitus. It functions as a sodium-glucose co-transporter 2 (SGLT2) inhibitor, which helps to lower blood glucose levels by preventing the reabsorption of glucose in the kidneys. This leads to increased excretion of glucose through urine, thereby reducing overall blood sugar levels. It is often prescribed when other diabetes medications have not provided adequate control. Additionally, Tofogliflozin has shown potential benefits in reducing cardiovascular risks, which is particularly important for diabetic patients who are at higher risk for heart-related complications. It is typically administered orally and is part of a comprehensive diabetes management plan that includes diet, exercise, and regular monitoring of blood glucose levels.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :